Curriculum Vitae

ASSOCIATE PROF. DR. R. JEYAKANTHA A/L RATNASINGAM

Associate Professor
  • Department of Medicine
    Faculty of Medicine
  • +603-79492868

BIOGRAPHY


Associate Professor Dr. Jeyakantha Ratnasingam obtained his undergraduate degree from the National University of Malaysia and his Masters Degree in Internal Medicine from University of Malaya. He completed his advanced training in endocrinology with the Ministry of Health Malaysia and had undergone a fellowship in endocrinology at the Princess Alexandra Hospital, Brisbane, Australia. He manages patients with type 2 and type 1 diabetes, osteoporosis, pituitary, thyroid, gonadal and adrenal disorders. To further pursue his interest in neuro-endocrinology, he has also undergone an attachment at the Auckland City Hospital Pituitary Centre in New Zealand and the Cambridge University's endocrine clinic at the Addenbrooke's Hospital in the United Kingdom. He is currently a senior consultant endocrinologist and the Head of Endocrinology at the University of Malaya Medical Centre, Kuala Lumpur.

Besides managing patients with endocrine disorders, he plays an active role in investigator as well as industry initiated clinical trials in the field of endocrinology, diabetes and osteoporosis. He has published papers in academic journals and actively speaks at scientific meetings. He is currently the council member of the Malaysian Endocrine and Metabolic Society, Diabetes Malaysia and the Malaysian Osteoporosis Society. He also sits on the editorial board of the Asian Journal of Diabetology. Dr. Jeya is particularly interested in the field of neuroendocrinology, aiming at improving outcomes for patients living with pituitary disorders.

AREAS OF EXPERTISE


  • ENDOCRINOLOGY
    Pituitary, Neuroendocrinology
  • ENDOCRINOLOGY
    Diabetes, Osteoporosis, Endocrinology
  • ENDOCRINOLOGY
    Internal Medicine, Endocrinology

ACADEMIC QUALIFICATION


  • MIntMed, (Internal Medicine)
    Universiti Malaya (UM)
  • MD, (Perubatan)
    Universiti Kebangsaan Malaysia (UKM)

ADMINISTRATIVE DUTIES


  • Steering Committee and HCP Training Task Force Lead
    17 Apr 2023 - 31 Dec 2028 (National)
  • Head of Unit
    20 Oct 2022 - 20 Oct 2024 (Department of Medicine, Faculty of Medicine)
  • Chairman
    24 Nov 2023 - 26 Nov 2023 (International)
  • Chairman
    01 Aug 2022 - 31 Dec 2022 (National)
  • Head of Unit
    11 Dec 2020 - 31 Oct 2022 (University Malaya)
  • Chairman
    17 Jan 2020 - 31 Dec 2020 (University Malaya)
  • Chairman
    14 Dec 2019 - 14 Dec 2019 (National)
  • Chairman
    01 Mar 2019 - 15 Oct 2019 (National)
  • Chairman
    30 Mar 2019 - 28 Jul 2019 (National)
  • Manager
    23 Jul 2018 - 22 Jul 2019 (Department of Medicine, Faculty of Medicine)
  • Examiner
    04 Jul 2018 - 04 Jul 2018 (Department of Medicine, Faculty of Medicine)
  • Examiner
    03 Jul 2018 - 03 Jul 2018 (Department of Medicine, Faculty of Medicine)
  • Examiner
    15 May 2018 - 15 May 2018 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    31 Mar 2016 - 30 Jun 2016 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    25 Sep 2012 - 25 Sep 2013 (University Malaya)

MEMBERSHIPS


  • COMMITTEE MEMBER, THERAPEUTIC USE EXEMPTIONS, MALAYSIAN ANTI-DOPING AGENCY, COMMITTEE MEMBER
    2023 to present (National)
  • COUNCIL MEMBER MALAYSIAN OSTEOPOROSIS SOCIETY, COMMITTEE MEMBER
    2022 to 2024 (National)
  • EDITORIAL BOARD MEMBER ASIAN JOURNAL OF DIABETOLOGY, EDITORIAL BOARD
    2022 to 2024 (International)
  • COUNCIL MEMBER, COMMITTEE MEMBER
    2022 to 2024 (National)
  • MALAYSIAN OSTEOPOROSIS SOCIETY, SECRETARY
    Since 2020 (National)
  • MALAYSIAN OSTEOPOROSIS SOCIETY, COMMITTEE MEMBER
    Since 2018 (National)
  • NATIONAL SPECIALIST REGISTER, ACTIVE MEMBER
    Since 2016 (National)
  • MALAYSIAN ENDOCRINE AND METABOLIC SOCIETY, COUNCIL MEMBER
    2020 to 2022 (National)

AWARD AND STEWARDSHIP


  • Best Oral Presenter, AFOS- KSO Award Recipient
    Korean Society of Osteoporosis, 2023 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2020 (University)
  • Excellence In Service Award 2016
    University Malaya, 2017 (University)
  • Best Poster Award, Malaysian Endocrine and Metabolic Society Annual Conference
    Malaysian Endocrine and Metabolic Society- MEMS, 2017 (International)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2017 (University)
  • Early Career Travel Award
    United States Endocrine Society, 2016 (International)
  • Young Investigators Runner up Award
    ASEAN Federation of Endocrine Societies, 2015 (International)
  • Travel Award
    International Society Of Endocrinology, 2012 (International)
  • American Diabetes Association Speaker Certification
    American Diabetes Association, 2012 (International)
  • Young Investigators Award for Best Oral Presentation
    ASEAN Federation of Endocrine Societies, 2011 (International)

PUBLICATIONS


Article in Journal
WoS
  1. Cheah, Min Hui; Lai, Pauline Siew Mei; Khor, Hui Min; Ratnasingam, Jeyakantha; Chandrasekaran, C. Sankara Kumar; Singh, Simmrat; Bin Zakaria, Mohd Idzwan; Ong, Terence (2023). Fragility fracture care gap at a tertiary teaching hospital in Malaysia, ARCHIVES OF OSTEOPOROSIS. 18(1). doi:10.1007/s11657-023-01256-4
  2. Hee, Nicholas Ken Yoong; Lim, Quan Hziung; Paramasivam, Sharmila; Lim, Lee Ling; Vethakkan, Shireene; Ganapathy, Shubash Shander; Ratnasingam, Jeyakantha (2023). The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency, CLINICAL ENDOCRINOLOGY. . doi:10.1111/cen.14999
  3. Tan, Hui-Ting; Tan, Cheng-Yin; Teong, Chee-Sin; Ratnasingam, Jeyakantha; Goh, Khean-Jin (2022). Prolonged Exercise Test in Patients With History of Thyrotoxicosis, JOURNAL OF CLINICAL NEUROPHYSIOLOGY. 39(4), 307-311. doi:10.1097/WNP.0000000000000766
  4. Oo, M. M., Zhen, I. T. C., Ng, K. S., Tan, K. L., Tan, A. T. B., Vethakkan, S. R., . . . Chee, K. H. (2021). Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease. BMJ Open, 11(1), 8. doi: 10.1136/bmjopen-2020-039869
  5. Sandhu, A. K., Toh, L. S., Lee, Y. K., Tan, A. T. B., Ratnasingam, J., Thiagarajan, N., & Lai, P. S. M. (2021). Cross-Cultural Adaptation and Validation of the Malay Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia. Patient Preference and Adherence, 15, 1383-1395. doi: 10.2147/ppa.s314641
  6. Samsuddin, S., Arumugam, P. A., Amin, M. S. M., Yahya, A., Musa, N., Lim, L. L., . . . Vethakkan, S. R. (2020). Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity, and insulin resistance: a prospective observational cohort study. Bjog-an International Journal of Obstetrics and Gynaecology, 127(4), 490-499. doi: 10.1111/1471-0528.16031
  7. Zainuddin, N. M., Sthaneshwar, P., & Ratnasingam, J. (2020). Screening for phaeochromocytoma in patients with acute cerebrovascular disease: Is it necessary? Malaysian Journal of Pathology, 42(2), 203-207.
  8. Leong, S. H., Shander, S., Ratnasingam, J. (2018). PREDICTING RECOVERY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER PROLONGED GLUCOCORTICOID USE. Endocrine Practice, 24(1), 14-20. doi: 10.4158/ep-2017-0074
  9. Rama Chandran, S., Tay, W. L., Lye, W. K., Lim, L. L., Ratnasingam, J., Tan, A. T. B., Gardner, D. S. L. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes. Diabetes Technology Therapeutics, 10. doi:10.1089/dia.2017.0388
ESCI
  1. Wong, Albert Hing; Wong, Wei-Kei; Looi, Lai-Meng; Ratnasingam, Jeyakantha; Lim, Soo-Kun (2022). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement, CASE REPORTS IN NEPHROLOGY AND DIALYSIS. 12(2), 105-111. doi:10.1159/000525182
Scopus
  1. Kalra S., Dhar M., Afsana F., Aggarwal P., Aye T.T., Bantwal G., Barua M., Bhattacharya S., Das A.K., Das S., Dasgupta A., Dhakal G., Dhingra A., Esfahanian F., Gadve S., Jacob J., Kapoor N., Latheef A., Mahadeb Y., Maskey R., Naseri W., Ratnasingam J., Raza A., Saboo B., Sahay R., Shah M., Shaikh S., Sharma S.K., Shrestha D., Somasundaram N., Tiwaskar M., Jawdekar A. (2022). Asian Best Practices for Care of Diabetes in Elderly (ABCDE), The review of diabetic studies : RDS. 18(2), 100-134. doi:10.1900/RDS.2022.18.100
  2. Wong A.H., Wong W.-K., Looi L.-M., Ratnasingam J., Lim S.-K. (2022). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement, Case Reports in Nephrology and Dialysis. 12(2), 105-111. doi:10.1159/000525182
  3. Rama Chandran, S., Tay, W. L., Lye, W. K., Lim, L. L., Ratnasingam, J., Tan, A. T. B., Gardner, D. S. L. (2018). Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes. Diabetes Technology and Therapeutics, 20(5), 353-362. doi: 10.1089/dia.2017.0388
Others
  1. Sandhu, A. K., Toh, L. S., Lee, Y. K., Tan, A., Ratnasingam, J., Thiagarajan, N., & Lai, P. (2021). Cross-Cultural Adaptation and Validation of the Malay Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia. Patient preference and adherence, 15, 1383 1395.
  2. Hui-Ting Tan, Cheng-Yin Tan, Chee-Sin Teong, Jeyakantha Ratnasingam, Khean-Jin Goh. Prolonged Exercise Test in Patients with History of Thyrotoxicosis, Journal of Clinical Neurophysiology (In Press)
  3. Samsuddin S, Arumugam PA, Md Amin MS, Yahya A, Musa N, Lim LL, Paramasivam SS, Ratnasingam J, Ibrahim L, Chooi KC, Tan ATB, Tan PC, Omar SZ, Samingan N, Kamar AA, Anuar Zaini A, Jalaluddin MY, Vethakkan SR. (2020). Maternal lipids are associated with newborn adiposity independent of GDM status, obesity and insulin resistance: a prospective observational cohort study. BJOG;127(4):490 499. doi:10.1111/1471-0528.16031 (IF 5.193)
  4. Rama Chandran S, Vigersky RA, Thomas A, Lim LL, Ratnasingam J, Tan A, Gardner DSL.Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels. Diabetes Technol Ther 2019 Oct 1. doi: 10.1089/dia.2019.0277. [Epub ahead of print]
  5. Zanariah Hussein, Mohamed Long Bidin, Azmi Alias, Muthukkumaran Thiagarajan, Kartikasalwah Abdul Latif, Jeyakantha Ratnasingam, Wan Juani Wan Seman, Azraai Nasruddin. Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly. Journal of ASEAN Federation of Endocrine Societies, 2019, 34(1): 8-14
  6. SS Paramasivam, K Chinna, AKK Singh, J Ratnasingam, L Ibrahim, LL Lim, ATB Tan, SP Chan, PC Tan, SZ Omar, RW Bilous, SR Vethakkan. Continuous Glucose Monitoring Results in Lower HbA1c in Malaysian Women with Insulin Treated Gestational Diabetes: A Randomized Controlled Trial. Diabetic Medicine
  7. Ratnasingam J, Lenders N, Ong B, Boros S, Russell AW, Inder WJ, Ho KKY. Predictors for secondary therapy after surgical resection of nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 2017; 87: 717 724 doi: 10.1111/cen.13402
  8. Sii Hoe Leong, Shubash Shander, Jeyakantha Ratnasingam, Predicting recovery of the hypothalamic pituitary adrenal axis after prolonged glucocorticoid use, Endocr Pract 2018; 24 (1)
  9. Thuzar M, Phillip Law W, Ratnasingam J, Jang C, Dimeski G, Ho KK. Glucocorticoids Suppress Brown Adipose Tissue Function In Humans: A Double-Blind Placebo-Controlled Study. Diabetes Obes Metab 2017 doi: 10.1111/dom.13157.
  10. Venugopal, Y., Hatta, S., Musa, N., Rahman, S. A., Ratnasingam, J., Paramasivam, S. S., Lim, L.L., Ibrahim, L., Choong, K., Tan, AT., Chinna, K., Chan, SP., Vethakkan, S. R. (2017). Maintenance vitamin D3 dosage requirements in Chinese women with post menopausal osteoporosis living in the tropics. Asia Pac J Clin Nutr, 26(3), 412-420. doi:10.6133/apjcn.042016.10 (IF 1.375)
  11. Jeyakantha Ratnasingam, Kheng Chiew Chooi, Syahrizan Samsuddin, Sharmila Paramasivam, Luqman Ibrahim, Lee Ling Lim,Alexander Tan, and Shireene Vethakkan (2016) VISUAL VIGNETTES-PERSISTENT HEADACHES WITH APPARENT EMPTY SELLA SYNDROME. Endocrine Practice In-Press. doi: http://dx.doi.org/10.4158/EP161568.VV
  12. Jeyakantha Ratnasingam, Luqman Ibrahim, Sharmila Paramasivam, Lee Ling Lim, Alexander Tan Tong Boon, Shireene Vethakkan. Asymmetrical bone loss in a patient with poliomyelitis: an indication for anti-osteoporotic therapy Clinical Cases in Mineral and Bone Metabolism, 2016; vol 13(1):61
  13. Lim LL, Brnabic AJ, Chan SP, Ibrahim L, Paramasivam SS, Ratnasingam J, Vethakkan SR, Tan AT.The Relationship of HbA1c , Fasting, and Postprandial Hyperglycemia in Subjects with Type 2 Diabetes Mellitus in Malaysia. J Diabetes Investig 2016 doi: 10.1111/jdi.12596. [Epub ahead of print]
  14. Lim, L.L., Shah, F.Z.M., Ibrahim, L., Paramasivam, S.S., Ratnasingam, J., Chan, S.P., Tan, A.T.B. and Vethakkan, S.R. Hypopituitarism in a Dengue Shock Syndrome Survivor without known Pituitary Adenoma, Tropical Biomedicine 2016, 33(4): 1 7
  15. Lee Ling Lim, Normayah Kitan, Sharmila Sunita Paramasivam, Jeyakantha Ratnasingam, Luqman Ibrahim, Siew Pheng Chan, Alexander Tong Boon Tan and Shireene Ratna Vethakkan. PRKAR1A-negative familial Cushing s syndrome: two case reports. Journal of Medical Case Reports (2015) 9:277. DOI 10.1186/s13256-015-0757-7 (SCOPUS-Cited Publication)
  16. J Ratnasingam, LL Lim, S Sunita Paramasivam, L Ibrahim, S Vethakkan, P Sthaneswar, SP Chan, ATT Tan. A LONGITUDINAL STUDY ON THE INTERRELATIONSHIPS BETWEEN HBA1C, FRUCTOSAMINE AND CONTINUOUS GLUCOSE MONITORING DERIVED MEAN BLOOD GLUCOSE IN TYPE 2 DM PATIENTS. Diabetes Research and Clinical Practice 2014; 106 (1): S91. DOI: 10.1016/S0168- 8227(14)70385-7 (ISI-Cited Publication)
  17. Ratnasingam J, Karim N, Paramasivam SS, Ibrahim L, Lim LL, Tan AT, Vethakkan SR, Jalaludin A, Chan SP. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary. 2014 Aug 19. [Epub ahead of print] Digital Object Identifier (DOI) 10.1007/s11102-014-0593-6 (ISI-Cited Publication)
  18. J. Ratnasingam, A.T.B. Tan, S.R. Vethakkan, S.S. Paramasivam, L. Ibrahim, L.L. Lim, K Choong. Primary Hyperparathyroidism: A Rare Cause of Genu Valgus in Adolescence. Journal of Clinical Endocrinology & Metabolism 2013; 98(3) 869 - 870
  19. S Faradila, L Ibrahim, SS Paramasivam, LL Lim, J Ratnasingam, ATB Tan, SR Vethakkan. Prevalence and Predictors of Vitamin D Inadequacy in a Multiracial Cohort of Vitamin D Supplemented Women with Post- menopausal Osteoporosis Living in the Tropics. Osteoporosis International. 2013; 24 (1): S385-391. DOI 10.1007/s00198-013-2315-8 (ISI-Cited Publication)
  20. Sharmila S Paramasivam, Shireene R Vethakkan, Tan ATB, Rohaya A Razak, J Ratnasingam, L Ibrahim, K Choong, R Pendek. 2012. Basal Insulin During Ramadhan: To Give at Prebed or Predawn ? Diabetes Asia Abstracts. National Diabetes Institute 11 : 71
Article in Proceeding
  1. ACROMEGALY WITH SPONTANEOUS VENTRICULOSTOMY A RARE PHENOMENON https://doi.org/10.15605/jafes.037.S2.47 Dorothy Maria Anthony Bernard, Lim Sue Wen, Nicholas Hee Ken Yoong, Lim Quan Hziung, Deviga Lachumanan, Sharmila Sunita Paramasivam, Lim Lee Ling, R. Jeyakantha Ratnasingam, Raja Rizal Azman Bin Raja Aman, Shireene Ratna DB Vethakkan
  2. DESCRIPTIVE COST ANALYSIS OF TELECONSULTATION IN UMMC DIABETES CLINIC https://doi.org/10.15605/jafes.037.S2.67 Nazri AB Kahar, Lim Quan Hziung, Luqman Ibrahim, Jeyakantha Ratnasingam, Shireene Vethakkan, Lee-Ling Lim, Sharmila Paramasivam
  3. Tilagamaty Murthy,1 Shubash Shander,2 Jeyakantha Ratnasingam,1 Lee Ling Lim,1 Shireene Vethakkan,1 Sharmila Paramasivam1 1 University Malaya Medical Centre, Malaysia 2 Institute for Public Health, National Institute of Health, Ministry of Health Malaysia
  4. VALUE OF 30 AND 60-MINUTE CORTISOL VALUE DURING SHORT SYNACTHEN TEST CAN WE DO AWAY WITH ONE OR THE OTHER? https://doi.org/10.15605/jafes.037.S2.66 Khoo Jun Kit,1 Pavai Sthaneswar,2 Shubash Shander Ganapathy,3 Jeyakantha Ratnasingam1

RESEARCH PROJECT


National
  1. 2023 - 2025, Fundamental Research Grant Scheme (FRGS)
    Elucidating The Water Adsorption Behaviour Dependent On The Functionalized Mxene To Improve The Performance Of Wearable Moisture Sensor For Chronic Wound Monitoring ( Co-Researcher)
  2. 2017 - 2020, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
    Promoting Active Ageing Among Postmenopausal Women: Assessing The Effectiveness Of An Osteoporosis Screening Program And Developing A Patient Resource Website ( Principal Investigator(PI))
  3. 2013 - 2014, Bantuan Kecil Penyelidikan (BKP)
    THE EFFECT OF PROFESSIONAL CONTINUOUS GLUCOSE MONITORING ON DIABETES MANAGEMENT, HYPOGLYCEMIA AND GLYCEMIC CONTROL IN INSULIN-REQUIRING GESTATIONAL DIABETES MELLITUS ( Principal Investigator(PI))
  4. 2019 - 2024, NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.
    SEMAGLUTIDE CARDIOVASKULAR OUTCOMES TRIAL IN PATIENTS WITH TYPE 2 DIABETES (SOUL) ( Co-Inventor)
  5. 2022 - 2024, DEPARTMENT OF MEDICINE (DOM)
    Prevalence and phenotypic variability of overweight and obesity among healthcare workers in University of Malaya Medical Centre ( Co-Researcher)
  6. 2022 - 2023, Novo Nordisk Pharma (Malaysia) Sdn Bhd
    COMBINE 3 - A 52 week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with insulin aspart, both treatment arms with or without oral anti diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. ( Co-Inventor)
  7. 2021 - 2023, Malaysian Endocrine and Metabolic Society Grant
    Diabetic Osteosarcopenia: Understanding the relationship between T2DM and musculoskeletal health, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
  8. 2022 - 2023, Malaysian Endocrine and Metabolic Society Research Grant
    Brain Natriuretic Peptide: A Predictor of Adverse Outcomes In Thyroid Storm, Ministry of Health Malaysia ( Co-Researcher)
  9. 2020 - 2022, Malaysian Endocrine and Metabolic Society
    Malaysian Acromegaly Registry, Clinical Research Center, Ministry of Health Malaysia ( Co-Researcher)
  10. 2017 - 2021, Bayer Co. (Malaysia) Sdn. Bhd.
    A Randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care. ( Co-Inventor)
  11. 2019 - 2021, Sanofi-Aventis (M) Sdn. Bhd
    A randomized, 24 week, active-controlled, open-label, 3-arm, parallel-group multicenter study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabetic drug(s) ( Co-Inventor)
  12. 2019 - 2021, Malaysian Endocrine and Metabolic Society Research Grant
    Hypothalamic Pituitary Dysfunction After Spontaneous Subarachnoid Haemorrhage: A Prospective Longitudinal Cohort Study ( Co-Inventor)
  13. 2017 - 2020, Bayer Co. (Malaysia) Sdn. Bhd.
    A Randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-drive Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetics mellitus and the clinical diagnosis of diabetic kidney disease. ( Co-Inventor)
  14. 2017 - 2020, Geran Penyelidikan Universiti Malaya (UMRG)
    Promoting Active Ageing Among Postmenopausal Women: Assessing The Effectiveness Of An Osteoporosis Screening Program And Developing A Patient Resource Website ( Co-Inventor)
  15. 2018 - 2019, NONE
    A Prospective Study On Prolonged Exercise Test in Thyrotoxicosis Patients ( Consultant)
  16. 2016 - 2018, Bantuan Kecil Penyelidikan (BKP)
    Neuroendocrine dysfunction post-spontaneous subarachnoid haemorrhage (SAH): a longitudinal cohort study ( Consultant)
  17. 2016 - 2017, NONE
    Predicting the recovery of hypothalamic-pituitary adrenal axis after prolonged glucorticoid use ( Co-Inventor)
  18. 2013 - 2014, Bantuan Kecil Penyelidikan (BKP)
    THE EFFECT OF PROFESSIONAL CONTINUOUS GLUCOSE MONITORING ON DIABETES MANAGEMENT, HYPOGLYCEMIA AND GLYCEMIC CONTROL IN INSULIN-REQUIRING GESTATIONAL DIABETES MELLITUS ( Co-Inventor)
  19. 2011 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Hypothalamic Ptuitary Dysfunction Amongst Nasopharyngeal Cancer Survivors ( Consultant)
Private
  1. 2023 - 2025, AstraZeneca Sdn Bhd
    CAREME (CARDIOLOGY-RENAL-METABOLIC) INTEGRATED CLINIC FOR TYPE II DIABETES MELLITUS PATIENTS ( Co-Inventor)
  2. 2023 - 2025, BIOMARKETING SERVICES (M) SDN. BHD.
    DNLITE- IVD 103 : A NOVEL BIOMARKER TO PREDICT PROGRESSION OF DIABETIC KIDNEY DISEASE ( Co-Inventor)
  3. 2021 - 2024, Private Funding
    Fracture Liasion Service (fls) In University Malaya Medical Centre (ummc) ( Co-Researcher)
  4. 2020 - 2022, Malaysian Endocrine and Metabolic Society
    Hypothalamic Pituitary Dysfunction After Spontaneous Subarachnoid Haemorrhage: A Prospective Longitudinal Cohort Study , Clinical Research Center, Ministry of Health Malaysia ( Co-Researcher)
International
  1. 2019 - 2024, Private Funding
    Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL) ( Co-Inventor)
  2. 2022 - 2023, Biomed Global Research Grant
    DNLITE- IVD 103 : A NOVEL BIOMARKER TO PREDICT PROGRESSION OF DIABETIC KIDNEY DISEASE, Ministry of Industry and Information Technology ( Co-Inventor)
  3. 2021 - 2022, ABBOT MANUFACTURING SINGAPORE PTE LTD
    A randomized controlled trial to determine the effects of a diabetes-specific formula on long-term glycemic control and short-term glycemic variability in individuals with type 2 diabetes. ( Co-Researcher)
  4. 2019 - 2022, KPM (JPT), Medical Research Council, UK (MRC,UK)
    Using big data to improve population health and resource allocation for people with diabetes in Malaysia ( Co-Researcher)
  5. 2019 - 2022, KPM (JPT), Medical Research Council, UK (MRC,UK)
    Using big data to improve population health and resource allocation for people with diabetes in Malaysia ( Co-Researcher)
  6. 2019 - 2020, Private Funding
    A randomized 24 week, , active controlled, open-label, 3 arm , parallel group multicentre study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral diabetic drug(s) ( Co-Inventor)
  7. 2018 - 2019, International Funding
    DIARAMADAN: Observational study program assessing effectiveness and tolerability of gliclazide MR 60mg in patients with type 2 diabetes fasting during RAMADAN ( Co-Inventor)
  8. 2018 - 2019, Servier Malaysia
    Cost effectiveness of Diamicron MR and generic Gliclazide in preventing renal failure in Type 2 Diabetes Mellitus in the public sector of Malaysia ( Co-Inventor)
  9. 2017 - 2018, International Funding
    A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER-6), Novo Nordisk ( Co-Inventor)
  10. 2017 - 2018, Bayer Co. (Malaysia) Sdn Bhd
    Finerenone in reducing cardiovascular mortality and morbidity in Diabetic Kidney Disease (FIGARO-DKD), ( Co-Inventor)
  11. 2014 - 2016, International Funding
    Using Diabetic Kidney Disease Registry To Treat Multiple Targets (DKD-TMT) ( Consultant)
  12. 2014 - 2016, Johnson & Johnson Pharmaceutical Research & Development
    Canagliflozin Cardiovascular Assessment Study (CANVAS), Johnson & Johnson Pharmaceutical Research & Development ( Consultant)
  13. 2014 - 2016,  Janssen, a division of Johnson & Johnson Sdn Bhd (3718-D)
    Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects with T2DM (CANVAS-R) ( Consultant)

CONSULTANCY PROJECT


  • Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (Fidelio-Dkd), Bayer Co. (Malaysia) Sdn Bhd, Bayer Co.
    01 Jul 2017 - 01 Jul 2018 (International)
  • Malaysian Consensus On Acromegaly, Malaysian Endocrine and Metabolic Society
    01 Jul 2018 - 01 Jul 2018 (National)
  • A Trial Investigating The Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (Pioneer-6), Novo Nordisk, Novo Nordisk
    01 Jul 2017 - 01 Jul 2018 (International)
  • Malaysian Clinical Practice Guidelines On Thyroid Disorders, Malaysian Endocrine and Metabolic Society
    01 Jul 2017 - 01 Jul 2018 (National)
  • Using a Diabetic Kidney Disease (Dkd) Registry to Treat Multiple Targets (Tmt) Dkd Tmt, Asian Diabetes Foundation
    01 Jul 2015 - 01 Jul 2017 (International)
  • Malaysian Endocrine and Metabolic Society Annual Congress 2017, MEMS
    01 Jul 2017 - 01 Jul 2017 (International)
  • Study of The Effects of Canagliflozin On Renal Endpoints in Adult Subjects With T2dm (Canvas-R), Janssen, a Division of Johnson & Johnson Sdn Bhd (3718-D), Johnson & Johnson Sdn Bhd
    01 Jul 2016 - 01 Jul 2016 (International)
  • Canagliflozin Cardiovascular Assessment Study (Canvas), Johnson & Johnson Pharmaceutical Research & Development L.L.C., Johnson & Johnson Pharmaceutical
    01 Jul 2016 - 01 Jul 2016 (International)
  • Joint Asia Diabetes Evaluation Vs. Diabetes Monitoring Database (Jade Vs. Diamond), Asian Diabetes Foundation, Asian Diabetes Foundation
    01 Jul 2013 - 01 Jul 2013 (International)

PAPER PRESENTED


INVITED SEMINAR
  1. Metabolic Syndrome, Nurses Diabetes Workshop, UMMC (University) (27 Sep 2016 - 27 Sep 2016)
  2. Use of insulin analogues in pregnancy, Novo Nordisk Diabetes Summit, Novo Nordisk Malaysia (National) (16 Apr 2016 - 16 Apr 2016)
INVITED SPEAKER
  1. Type 2 Diabetes : Is there any chance to reverse ?, Hospital Serdang Diabetes Update 2023, Hospital Serdang (National) (15 Nov 2023 - 15 Nov 2023)
  2. Age-dependent FRAX-based Assessment and Intervention Thresholds for Therapeutic Decision Making in Osteoporosis in the Malaysian Population, International Congress In Osteoporosis, Korean Society of Osteoporosis (International) (04 Nov 2023 - 05 Nov 2023)
  3. Diabetes Remission, Diabetes Asia Conference, National Diabetes Institute (National) (12 Oct 2023 - 12 Oct 2023)
  4. Thyroiditis from Immune Check Point Inhibitors, Diabetes and Endocrine Conference, Indian Endocrine Society (International) (05 Aug 2023 - 05 Aug 2023)
  5. Incidentally Found Pituitary Adenomas, MEMS Annual Congress, Malaysian Endocrine and Metabolic Society (National) (07 Jul 2023 - 09 Jul 2023)
  6. Managing Diabetes Complications, World Diabetes Day, Diabetes Care Unit, UMMC (University) (15 Nov 2016 - 15 Nov 2016)
  7. Initiating Basal Insulin, Insulin Workshop, Sanofi Malaysia (National) (03 Sep 2016 - 03 Sep 2016)
  8. New Technologies for Diabetes Management, Diabetes Prevention and Management (29 Nov 2013 - 30 Nov 2014)
  9. Prevent the Preventable, World Diabetes Day Celebration University Malaya Medical Centre (22 Nov 2013 - 22 Nov 2013)
  10. Initiation of Basal and Basal Plus Insulin, Incretin Workshop (17 May 2013 - 18 May 2013)
  11. Management of Diabetes in the Renal Impaired, Together It Is Easier 2013 (12 Jan 2013 - 12 Jan 2013)
  12. Newer Therapies for Type 2 Diabetes, Primary Care Conference (06 Jul 2012 - 06 Jul 2012)
  13. Management of Obese Diabetics, UMMC Primary Care CME (24 Mar 2012 - 24 Mar 2012)
ORAL PRESENTER
  1. Early Prevalence of Neuroendocrine Dysfunction after Spontaneous Aneurysmal Subarachnoid Hemorrhage: Interim findings From A Prospective cohort Study, US Endocrine Society Annual Meeting, US Endocrine Society (International) (23 Mar 2019 - 23 Mar 2019)
  2. Predictors of Further Treatment After Surgical Resection of Non Functioning Pituitary Adenomas, ASEAN Federation of Endocrine Society Conference 2015, AFES (International) (12 Dec 2015 - 12 Dec 2015)
  3. Hypothalamic Pituitary Dysfunction Amongst Nasopharyngeal Cancer Survivors, ASEAN Federation of Endocrine Societies Meeting (18 Nov 2011 - 20 Nov 2011)
POSTER PRESENTER
  1. Assessing the effectiveness of an interprofessional collaborative osteoporosis screening program (IPC-OSP) in a Malaysian primary care setting: Preliminary findings (poster). , Australasian Pharmaceutical Science Association conference, Australasian Pharmaceutical Science Association (International) (01 Dec 2019 - 04 Dec 2019)
  2. Predicting the recovery of hypothalamic pituitary adrenal axis after prolonged glucocorticoid use, Malaysian Endocrine and Metabolic Society Annual Conference , Malaysian Endocrine and Metabolic Society (International) (19 May 2017 - 21 May 2017)
  3. Predictors of Secondary Therapy After Surgical Resection of Non-Functioning Pituitary Adenomas, US Endocrine Society Annual Meeting, U S Endocrine Society (International) (01 Apr 2016 - 04 Apr 2016)
  4. Use of Cabergolline For Persistent Cushing's Disease After Trans-sphenoidal Surgery : An Illustrated Case Report, ASEAN Federation of Endocrine Societies Conference 2015, AFES (International) (12 Dec 2015 - 12 Dec 2015)
  5. Interelationship Between HbA1c, Fructosamine and Glycated Albumin in Malaysian T2DM Patients, International DIabetes Federation, IDF (International) (05 Dec 2014 - 05 Dec 2014)
  6. Basal Insulin During Ramadhan : To give at Prebed or Predawn?, Diabetes Asia Conference 2012 (National) (17 Oct 2012 - 21 Oct 2012)
  7. Increased risk of hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors with the use of concurrent chemoirradiation, 15th International and 14th European Congress of Endocrinology (05 May 2012 - 09 May 2012)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2023) Judge for Oral Presentations Mems Annual Congress 2023, National, (External Evaluator)
  2. (2023) Article Reviewer, International, (Reviewer)
  3. (2022) Mmed Thesis Examination Uitm, National, (External Examiner)
  4. (2022) Article Reviewer, International, (Reviewer)
  5. (2022) Article Reviewer, International, (Reviewer)
  6. (2022) Reviewer of Article, International, (Reviewer)
  7. (2022) Thesis Proposal Evaluator, University, (Internal Assessor)
  8. (2022) Evaluation for Lecturer Post Department of Medicine, University, (Internal Assessor)
  9. (2021) Candidature Proposal Defence for Phd- Nur Nabilah Akmal Hashim, University, (Internal Examiner)
  10. (2021) Clinical Masters in Int Med Thesis Progress Evaluation, University, (Internal Assessor)
  11. (2021) Clinical Masters in Internal Medicine - Thesis Progress Evaluation, University, (Internal Assessor)
  12. (2021) Internal Assessor Malaysia Toray Science Foundation (Mtsf) Research Grant, University, (Internal Assessor)
  13. (2021) Internal Assessor Malaysia Toray Science Foundation (Mtsf) Grant Application, University, (Internal Assessor)
  14. (2021) Clinical Masters in Internal Medicine- Thesis Progress Evaluation, University, (Internal Assessor)
  15. (2018) BMC Women's Health Supplement Journal, (Reviewer)
Contribution to external organisation
  1. (2023) Course Director and Scientific Chair, National, (Resource Person)
  2. (2023) Expert Panel and Advisor for Mims Obesity Advisory Board, National, (Technical Advisor)
  3. (2023) Advisory Board Expert Panel for Finerenone, National, (Technical Advisor)
  4. (2023) Course Director and Scientific Chairperson, University Malaya Pituitary Preceptorship 2023, International, (Resource Person)
  5. (2022) Conceptualisation and Event Organisation- UM Advanced Course in Diabetes, National, (Expert Advisor)
  6. (2022) Global Advisory Board Member On The Enf New Intermediate Strength/ Liquid T4, International, (Expert Advisor)
  7. (2022) International Advisory Board Member for The Euthyrox New Formulation, International, (Expert Advisor)
  8. (2022) Malaysian Clinical Practice Guidelines for The Management of Osteoporosis, National, (Expert Advisor)
  9. (2021) Steering Committee- First South Asian Consensus On Geriatric Diabetes, International, (Expert Advisor)
  10. (2021) Advisory Board - Once Weekly Semaglutide, National, (Expert Advisor)
  11. (2021) Global Advisory Board Euthyrox New Formulation, International, (Expert Advisor)
  12. (2021) Advisory Board for Insulin Idegasp, National, (Expert Advisor)
  13. (2021) Malaysian Clinical Practice Guidelines for The Management of T2dm, National, (Expert Advisor)
Contribution to event
  1. (2023) Organising Chairperson Malaysian Osteoporosis Society Annual Scientific Meeting 2023, International, (Event Organiser)
  2. (2021) Expert Case Discussant - Translating Guidelines to Clinical Practice in Acromegaly, International, (Panelist/Moderator)
  3. (2021) Invited Speaker - Addressing An Unmet Need for Glds With Cardio-Renal Benefits, National, (Panelist/Moderator)
  4. (2021) National Gp Forum- Expert Panelist, National, (Panelist/Moderator)
  5. (2021) Diabetes Malaysia Webinar Series, International, (Event Organiser)
  6. (2021) Mems Annual Meeting - Invited Speaker- Pituitary Stalk Thickening, National, (Panelist/Moderator)
  7. (2021) Osteoporosis Webinar Series, International, (Event Organiser)
  8. (2021) Invited Speaker- Ece 2021 Digital Congress Update, National, (Panelist/Moderator)
  9. (2021) Invited Speaker- Diabetes and Dialysis, National, (Panelist/Moderator)
Media appearance
  1. (2022) World Diabetes Day Awareness- Rtm 2 Tamil News, National, (Interview)
  2. (2022) World Diabetes Day- Bernama News, National, (Interview)
  3. (2022) Prediabetes Awareness Amongst Malaysians, National, (Panelist/Moderator)
  4. (2022) Changing The Trajectory of Diabetes Care- Berita Mma, National, (Discourse)
  5. (2022) Gangguan Hormon Berisiko Membawa Maut- Berita Harian, National, (Interview)
  6. (2022) World Thyroid Day Awareness On Thyroid Disorders- Bernama News, National, (Interview)
  7. (2021) Mims Malaysia Article - Clinical Benefits of Flash Glucose Monitoring With Freestyle Libre, International, (Interview)

SUPERVISION


Postgraduate Student
Master
  1. (2023) Assessing the Effectiveness of an Interprofessional Collaborative Osteoporosis Screening Programme among Postmenopausal Women in Primary Care, ANISHA KAUR SANDHU
  2. (2022) -, NUSRATH SALMA FAROOK
  3. (2021) -, SYARMIMI AMIRA BINTI MUSTAFA
  4. (2020) Prevalence and Predictors of Opioid Endocrinopathy Amongst Patients With Non- Cancer Pain, Nurul Izzah
  5. (2020) FRAX based Predictors of Osteoporosis Amongst Post Menopausal Women Undergoing Bone Density in UMMC, Shanmugam Mariappan
  6. (2020) -, JASMEET KAUR
  7. (2019) Opioid- induced endocrinopathy in Malaysian subjects: prevalence and treatment, Ooi XY
  8. (2019) Hypothalamic Pituitary Dysfunction After Spontaneous Subarachnoid Haemorrhage: A Prospective Longitudinal Cohort Study, Ram Prasad Sinnanaidu
  9. (2019) Determining Malaysian Fracture Intervention Thresholds for Osteoporosis, Maram Niyaz
  10. (2019) Assessing the effectiveness of an interprofessional collaborative osteoporosis screening program (IPC-OSP) in a Malaysian primary care setting: Preliminary findings, Anisha Sandhu
  11. (2019) REAL WORLD EVIDENCE FOR THE USE OF SGLT2-INHIBITORS AMONGST PATIENTS WITH TYPE 2 DIABETES AT A TERTIARY CARE HOSPITAL IN MALAYSIA, ANANTHARAJU A/L RAMACHANDARAM
  12. (2018) -, CHARLEEN BLANGKAT ANAK JIM
  13. (2017) Adiponectin As A Predictor Of Insulin Therapy In Gestational Diabetes Mellitus, Lim Quan Hziung
  14. (2017) -, RAM PRASAD A/L SINNANAIDU
  15. (2017) -, SHANMUGAM A/L MARIYAPPAN
  16. (2016) Pituitary Dysfunction After Subarachnoid Haemorrhage, Chooi Kheng Chiew
  17. (2016) Effects of Dapagliflozin on Clinical, Metabolic & Renal Parameters Amongst Malaysian Patients with Type 2 Diabetes : A Single Centre Audit, 2017, Ho Hee Khean
  18. (2016) MALE HYPOGONADISM ACROSS PITUITARY SURGERY, ADRIAN NICHOLAS LIM CHOON SENG
  19. (2016) ADIPONECTIN AS A PREDICTOR OF INSULIN THERAPY IN GESTATIONAL DIABETES MELLITUS, LIM QUAN HZIUNG
  20. (2016) -, AHMED ALI
  21. (2015) Vitamin D Dose Supplementation Requirements Amongst Indian and Malay Women In the Tropics, Goh Kian Guan
  22. (2015) An Interim Analysis of Predictive Factors for Insulin Therapy In Asian Gestational Diabetes, Md Syazwan Bin Md Amin
  23. (2014) -, KEJAL A/P HASMUKHARAY
  24. (2013) THE EFFECT OF DAPAGLIFLOZIN ON CLINICAL METABOLIC AND RENAL PARAMETERS IN TYPE 2 DIABETIC PATIENT IN UNIVERSITY OF MALAYA MEDICAL CENTRE: A SINGLE CENTRE EXPERIENCE, HO HEE KHEEN
  25. (2012) Prevalence of Vitamin D Deficiency in Post Menopausal Osteoporosis in Malaysia, Sharifah Faradhila
  26. (2012) -, GOH KIAN GUAN
  27. (2012) An Interim Analysis Of Antenatal Predictors Of Insulin Therapy In Asian Gestational Diabetes, MD SYAZWAN BIN MD AMIN
  28. (2008) PREVALENCE OF VITAMIN D DEFICIENCY IN POST MENOPAUSAL OSTEOPOROSIS IN MALAYSIA, SHARIFAH FARADILA BINTI WAN MUHAMAD HATTA
Under Graduate Students
  1. (2016) MBBS Elective Project : Predicting the recovery of hypothalamic-pituitary adrenal axis after prolonged glucorticoid use
  2. (2013) MBBS Elective Project : Audit of Levo-thyroxine Replacement Amongst Patients with Primary Hypothyroidism

TEACHING


Master
  1. (2023) NA - Master of Internal Medicine
  2. (2022) MMed - Master in Internal Medicine
  3. (2018) 000 - Master Internal Medicine
  4. (2017) 000 - Master Internal Medicine
  5. (2012) 000 - Master Internal Medicine
  6. (2011) 000 - Master Internal Medicine
Bachelor
  1. (2023) NA - Ummp Stage 2.0
  2. (2023) NA - Ummp Stage 2 Clinical Days
  3. (2023) NA - Ummp Stage 3.1
  4. (2023) NA - Ummp Stage 3.3.
  5. (2022) UMMP - Ummp Stage 2 Cohort 2020
  6. (2022) UMMP - Ummp Stage 3.3 Cohort 2017
  7. (2018) 000 - Bachelor of Medicine Bachelor of Surgery
  8. (2017) 000 - Bachelor of Medicine Bachelor of Surgery
  9. (2015) 000 - Bachelor of Medicine Bachelor of Surgery
  10. (2013) 000 - Bachelor of Medicine Bachelor of Surgery
  11. (2013) DXED3102 - Human Disease- Bachelor Dental Surgery

SOCIAL RESPONSIBILITY ACTIVITIES


  • Organising Chair and Invited Speaker- Malaysian Endocrine and Metabolic Society (Mems) and Malaysian Society of Nephrology (Msn)- Diabetic Kidney Disease Workshop -12 Dec 2020, Kl, (12 Dec 2020 - 12 Dec 2020)
  • Organising Chair and Invited Speaker- Thyroid Webinar On Subclinical Thyroid Disease- Ppum and Merck Malaysia- 18 Nov 2020, Kl, (18 Nov 2020 - 18 Nov 2020)
  • Prediabetes Public Awareness Video Online- Lets Make a Change 13 Nov 2020, (13 Nov 2020 - 13 Nov 2020)
  • Invited Speaker- Translating Clinical Evidence in a Real World Setting- Masterclass in Diabetes Management- 3 Oct 2020, Kl, (03 Oct 2020 - 03 Oct 2020)
  • Invited Speaker- Train The Trainer- Ministry of Health Endocrine Division Research Workshop- 1 Oct 2020, Putajaya, (01 Oct 2020 - 01 Oct 2020)
  • Invited Speaker- Webinar On Parathyroid Bone Disease- Fragility Fracture Network Malaysia, 17 Sept 2020, (17 Sep 2020 - 17 Sep 2020)
  • Invited Speaker- Ummc Primary Care Insulin Workshop- 12th Sept 2020, Kl, (12 Sep 2020 - 12 Sep 2020)
  • Invited Speaker – Malaysian Osteoporosis Society – to Treat or Not to Treat, 15 Aug 2020, (15 Aug 2020 - 15 Aug 2020)
  • Invited Speaker Malaysian Medical Association- Webinar- Diabetes and Covid-19, 15th May 2020, (15 May 2020 - 15 May 2020)
  • Executive Committee Member, Guideline Development Group- Malaysian Clinical Practice Guideline for The Management of Type 2 Dm - 2020, (01 Mar 2020 - 31 Dec 2020)
  • Organising Chairperson, Ummc Thyroid Workshop 2019, (14 Dec 2019 - 14 Dec 2019)
  • Invited Speaker, Treatment Updates On Osteoporosis, World Congress of Falls and Postural Stability Post Congress Workshop, (07 Dec 2019 - 07 Dec 2019)
  • Newspaper Interview China Press World Diabetes Day, (14 Nov 2019 - 14 Nov 2019)
  • Invited Speaker, Pitfalls in Dxa, Hospital Putrajaya Endocrine Updates, (22 Oct 2019 - 22 Oct 2019)
  • Scientific Chairperson, Malaysian Society of Osteoporosis, Annual Scientific Meeting 2019, (12 Oct 2019 - 13 Oct 2019)
  • Scientific Chairperson, National Diabetes Conference 2019, (26 Jul 2019 - 28 Jul 2019)
  • Invited Speaker Tackling Cardiovascular Disease in T2dm Endocrine Update- Hospital Tuanku Ampuan Rahimah, (26 Apr 2019 - 26 Apr 2019)
  • Invited Speaker - New Generation Basal Insulin Brunei Diabetes Update, (20 Apr 2019 - 20 Apr 2019)
  • Invited Plenary Speaker, Private Practitioners Association of Selangor and Kuala Lumpur, Annual Scientific Congress 6-7 April 2019, (06 Apr 2019 - 07 Apr 2019)
  • Invited Speaker : Understanding Oral Anti- Diabetic Choices for T2dm Private Medical Practitioners' Association of Selangor and Kuala Lumpur, (06 Apr 2019 - 07 Apr 2019)
  • Invited Speaker : Malaysian Society of Hypertension, (18 Jan 2019 - 18 Jan 2019)
  • Invited Speaker : Managing Side Effects of Steroids 1st Oncology Summit by Malaysian Urological Society, Malaysian Medical Association and Janssen, (12 Jan 2019 - 12 Jan 2019)
  • Invited Speaker - Medical Management of Acromegaly Malaysian Acromegaly Summit, (20 Oct 2018 - 20 Oct 2018)
  • Radio Interview Minnal Fm On Hypertension, (04 Jun 2018 - 04 Jun 2018)
  • Organising Chairperson and Speaker for Thyroid Workshop, (03 Mar 2018 - 03 Mar 2018)
  • Public Forum : What You Need to Know About Osteoporosis, (04 Nov 2017 - 04 Nov 2017)
  • Invited Speaker, Central Diabetes Workshop 2017, (28 Oct 2017 - 28 Oct 2017)
  • Speaker, Diabetes Asia Conference, National Diabetes Institute, (13 Oct 2017 - 15 Oct 2017)
  • Faculty Member and Speaker, Ascend Diabetes Workshop 2017, (30 Sep 2017 - 01 Oct 2017)
  • Organising Chairperson and Speaker: Ummc Insulin Workshop 2017, (19 Aug 2017 - 19 Aug 2017)
  • Article in Magazine : Be Positive in The Battle Against Diabetes, Berita Kontrol, (01 Aug 2017 - 30 Sep 2017)
  • Organsing Committee Member : Malaysian Endocrine and Metabolic Society Annual Congress, Mac 8, (19 May 2017 - 21 May 2017)
  • Organising Chairperson and Speaker, Osteoporosis Workshop : Know Your Bones, (04 Mar 2017 - 04 Mar 2017)
  • Expert Panel, Malaysian Clinical Practice Guidelines for Thyroid Disorders, (01 Feb 2017 - 31 Dec 2017)
  • Public Forum : Diabetes in Malaysia, Malaysian Dental Association 24th Annual Congress, (15 Jan 2017 - 15 Jan 2017)
  • Television Interview for World Diabetes Day 2016; Astro V Buzz, (07 Nov 2016 - 07 Nov 2016)
  • Public Lecture World Diabetes Day 2013 : Prevent The Preventable, (22 Nov 2013 - 22 Nov 2013)

COURSE ATTENDED


Internal / External Course
CONFERENCE
  1. AAZPIRE- ACADEMIC ASTRA ZENECA PROGRAM FOR INTERNATIONAL REGIONAL EXPERTS, Istanbul, Turkey (29 Jun 2022 - 02 Jul 2022)
RESEARCH
  1. THE ROLE OF BONE MINERAL DENSITY ADDED TO FRACTURE RISK ASSESSMENT TOOL (FRAX) IN THERAPEUTIC DECISION MAKING FOR OSTEOPOROSIS, (15 Jul 2022 - 12 Oct 2022)